Skip to main content

Other Medications: Desmopressin, Pyridostigmine, Erythropoietin and SSRIs

  • Chapter
  • First Online:
Postural Tachycardia Syndrome

Abstract

Most therapeutic options for PoTS are covered in other chapters on pharmacological approaches in this text book; however patients with PoTS may continue to be symptomatic despite being treated with a combination of volume expander (fludrocortisone) and vasoconstrictor (midodrine). Here consideration is limited to four additional classes of therapy which may be of benefit when conventional approaches have failed:

  • Anti-diuretic treatment (Desmopressin)

  • Acetylcholinesterase inhibition (pyridostigmine)

  • Colony stimulating factors (erythropoietin)

  • Selective serotonin reuptake inhibitors (SSRI).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Richardson DW, Robinson AG. Desmopressin. Ann Intern Med. 1985;103(2):228–39.

    Article  CAS  Google Scholar 

  2. Ahmad RA, Watson RD. Treatment of postural hypotension. Rev Drugs. 1990;39(1):74–85.

    CAS  Google Scholar 

  3. Coffin ST, Black BK, Biaggioni I, Paranjape SY, Orozco C, Black PW, et al. Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 2012;9(9):1484–90.

    Article  Google Scholar 

  4. Raj SR. Postural tachycardia syndrome (POTS). Circulation. 2013;127(23):2336–42.

    Article  Google Scholar 

  5. Gales BJ, Gales MA. Pyridostigmine in the treatment of orthostatic intolerance. Annals Pharmacoth. 2007;41(2):314–8.

    Article  CAS  Google Scholar 

  6. Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation. 2005;111(21):2734–40.

    Article  CAS  Google Scholar 

  7. Kanjwal K, Karabin B, Sheikh M, Elmer L, Kanjwal Y, Saeed B, et al. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing Clin Electrophy. 2011;34(6):750–5.

    Article  Google Scholar 

  8. Elliott S, Pham E, Macdougall IC. Erythropoietins: a common mechanism of action. Exp Hematol. 2008;36(12):1573–84.

    Article  CAS  Google Scholar 

  9. Fishbane S, Besarab A. Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets. Clin J Am Soc Nephrol. 2007;2(6):1274–82.

    Article  CAS  Google Scholar 

  10. Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med. 2007;120(10):841–7.

    Article  Google Scholar 

  11. Hoeldtke RD, Horvath GG, Bryner KD. Treatment of orthostatic tachycardia with erythropoietin. Am J Med. 1995;99(5):525–9.

    Article  CAS  Google Scholar 

  12. Kanjwal K, Saeed B, Karabin B, Kanjwal Y, Sheikh M, Grubb BP. Erythropoietin in the treatment of postural orthostatic tachycardia syndrome. Am J Ther. 2012;19(2):92–5.

    Article  Google Scholar 

  13. Guzman JC, Armaganijan LV, Morillo CA. Treatment of neurally mediated reflex syncope. Cardiol Clin. 2013;31(1):123–9.

    Article  Google Scholar 

  14. Sharma T, Guski LS, Freund N, Gotzsche PC. Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ. 2016;352:i65.

    Article  Google Scholar 

  15. Grubb BP. Postural tachycardia syndrome. Circulation. 2008;117(21):2814–7.

    Article  Google Scholar 

  16. Mar PL, Raj V, Black BK, Biaggioni I, Shibao CA, Paranjape SY, et al. Acute haemodynamic effects of a selective serotonin reuptake inhinitor in postural tachycardia syndrome: a radnomized crossover trial. J Psychopharmacol. 2014;28(2):155–61.

    Article  Google Scholar 

  17. Green EA, Raj V, Shibao CA, Biaggioni I, Black BK, Dupont WD, et al. Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome. J Am Heart Assoc. 2013;2(5):e000395.

    Article  Google Scholar 

  18. Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar. J Am Coll Cardiol. 2019;73(10):1207–28.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehran Asgari .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Asgari, M., Lobo, M.D. (2021). Other Medications: Desmopressin, Pyridostigmine, Erythropoietin and SSRIs. In: Gall, N., Kavi, L., Lobo, M.D. (eds) Postural Tachycardia Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-54165-1_34

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-54165-1_34

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-54164-4

  • Online ISBN: 978-3-030-54165-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics